BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 15584434)

  • 1. [Toxicological significance of biological markers].
    Manno M; Sannolo N
    G Ital Med Lav Ergon; 2004; 26(4):270-7. PubMed ID: 15584434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomonitoring for occupational health risk assessment (BOHRA).
    Manno M; Viau C; ; Cocker J; Colosio C; Lowry L; Mutti A; Nordberg M; Wang S
    Toxicol Lett; 2010 Jan; 192(1):3-16. PubMed ID: 19446015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biologically effective dose biomarkers].
    Miraglia N; Assennato G; Clonfero E; Fustinoni S; Sannolo N
    G Ital Med Lav Ergon; 2004; 26(4):298-301. PubMed ID: 15584436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure assessment at the workplace: implications of biological variability.
    Manini P; De Palma G; Mutti A
    Toxicol Lett; 2007 Feb; 168(3):210-8. PubMed ID: 17157456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic effects and biotoxicity monitoring of occupational styrene exposure.
    Rueff J; Teixeira JP; Santos LS; Gaspar JF
    Clin Chim Acta; 2009 Jan; 399(1-2):8-23. PubMed ID: 18845133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidance values for the biomonitoring of occupational exposure. State of the art.
    Aitio A
    Med Lav; 2006; 97(2):324-31. PubMed ID: 17017366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New biomarkers of exposure].
    Apostoli P; Bergonzi R; Catalani S; Neri G; Sarnico M; FoĆ  V; Fustinoni S; Colombi A; Buratti M; Campo L; Scibetta L; Sannolo N; Pieri M; Basile A; Bartolucci GB; Carrieri M; Scapellato ML; Manini P; Poli D; Corradi M; Andreoli R; Goldoni M; Mutti A; Imbriani M; Ghittori S; Maestri L; Negri S; Pira E; Pavan I; Discalzi G; Perbellini L
    G Ital Med Lav Ergon; 2004; 26(4):278-97. PubMed ID: 15584435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human exposure assessment to environmental chemicals using biomonitoring.
    Calafat AM; Ye X; Silva MJ; Kuklenyik Z; Needham LL
    Int J Androl; 2006 Feb; 29(1):166-71; discussion 181-5. PubMed ID: 16466536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biological monitoring of chemical exposure].
    Jakubowski M
    Med Pr; 2004; 55(1):13-8. PubMed ID: 15156762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biomarkers of neurotoxic effects induced by environmental chemicals].
    Indulski JA; Lutz W
    Med Pr; 1996; 47(4):383-91. PubMed ID: 8847985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Before the storm: informing and involving stakeholder groups in workplace biomarker monitoring.
    Musham C; Trettin L; Jablonski R
    J Public Health Policy; 1999; 20(3):319-34. PubMed ID: 10874405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of exposure at the work site by biological monitoring].
    Jost M
    Ther Umsch; 1989 Nov; 46(11):780-5. PubMed ID: 2688170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-environment interaction and biological monitoring of occupational exposures.
    Hirvonen A
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):329-35. PubMed ID: 15996696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
    Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ethical considerations on the planning, assessment and management of biological monitoring data].
    Van Damme K; Casteleyn L; Manno M
    G Ital Med Lav Ergon; 2004; 26(4):338-43. PubMed ID: 15584443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oncoproteins and anti-oncoproteins in blood serum as biomarkers of early health effects induced by occupational and environmental carcinogens].
    Lutz W; Krajewska B
    Med Pr; 1996; 47(5):511-8. PubMed ID: 9026631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.